MedPath

Psychological Treatment of Posttraumatic Stress Disorder and Moral Injury in Refugees

Not Applicable
Recruiting
Conditions
Posttraumatic Stress Disorder
Moral Injury
Mental Health - Other mental health disorders
Registration Number
ACTRN12622001048774
Lead Sponsor
Professor Angela Nickerson
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
12
Inclusion Criteria

Inclusion criteria for participants taking part in this study include:
1.18 years of age or older
2.PTSD diagnosis (according to DSM-5)
3.Exposure to a potentially morally injurious experience
4.Elevated trauma-related anger, shame or guilt
5.From a refugee or asylum seeker background
6.Fluent in Arabic, Dari, Farsi or English
7.Access to a smart phone, tablet or computer in order to complete sessions via telehealth on Zoom.

Exclusion Criteria

Exclusion criteria for those who are not eligible to participate in the study include:
1.Acute suicidality that cannot be safely managed in the clinic setting (i.e., intent and/or previous suicide attempt in the past three months).
2.Active/untreated psychosis
3.Alcohol or Substance dependence
4.Moderate to Severe Traumatic Brain Injury
5.Concurrent regular psychological therapy

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
PTSD diagnosis as measured by the PTSD Symptom Scale Interview for the DSM-5 (PSS-I-5).[ Baseline (before baseline length allocation), Pre-treatment (after baseline completion), Post-treatment and follow-up (3 months post-completion of intervention). Post-treatment is defined as the primary endpoint. ];Posttraumatic stress symptoms as measured by the PTSD Symptom Scale Interview for the DSM-5 (PSS-I-5). [ Baseline (before baseline length allocation), Pre-treatment (after baseline completion), Post-treatment and follow-up (3 months post-completion of intervention). Post-treatment is defined as the primary endpoint. ];Posttraumatic stress symptoms as measured by the PTSD-8 (PTSD-8). [ Baseline (before baseline length allocation), Pre-treatment (after baseline completion), Post-treatment and follow-up (3 months post-completion of intervention). Additionally, the PTSD-8 is completed weekly throughout the baseline and treatment phases. Post-treatment is defined as the primary endpoint. ]
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath